IP Library › Granted Patent US 7,611,893
Granted Patent B2
US 7,611,893 · App. 11/725,672 · Granted Nov 3, 2009

Metal-binding therapeutic peptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,611,893
App. No.
11/725,672
Granted
Nov 3, 2009
Kind
B2
Abstract

The present invention is related methods of delivering MBD peptide-linked agents into live cells. The methods described herein comprise contacting MBD peptide-linked agents to live cells under a condition of cellular stress. The methods of the invention may be used for therapeutic or diagnostic purposes.

Claims (24)

1. A polypeptide comprising the amino acid sequence KKGFYKKKQCRPSKGRKRGFCWAVAEYARVQKRK (SEQ ID NO: 21).

2. A composition comprising the polypeptide of claim 1 and a pharmaceutical excipient.

3. A nucleic acid encoding the polypeptide of claim 1 .

4. A vector comprising the nucleic acid of claim 3 .

5. A polypeptide comprising the amino acid sequence KGFYKKKQCRPSKGRKRGFCWAVAEYARVQKRK (SEQ ID NO: 46).

6. A composition comprising the polypeptide of claim 5 and a pharmaceutical excipient.

7. A nucleic acid encoding the polypeptide of claim 5 .

8. A vector comprising the nucleic acid of claim 7 .

9. A polypeptide comprising the amino acid sequence AVAEYARVQKRKGFYKKKQCRPSKGRKRGFCWKALYWDLYE (SEQ ID NO :213).

10. A composition comprising the polypeptide of claim 9 and a pharmaceutical excipient.

11. A nucleic acid encoding the polypeptide of claim 9 .

12. A vector comprising the nucleic acid of claim 11 .

13. A polypeptide comprising the amino acid sequence AVAEYAWVQKRKGFYKKKQCRPSKGRKRGFCWKALYWDLYE (SEQ TD NO:2 14).

14. A composition comprising the polypeptide of claim 13 and a pharmaceutical excipient.

15. A nucleic acid encoding the polypeptide of claim 13 .

16. A vector comprising the nucleic acid of claim 15 .

17. A polypeptide comprising the amino acid sequence ETFSDVWKLLKKGFYKKKQCRPSKGRKRGFCWAVAEYARVQKRK (SEQ ID NO:222).

18. A composition comprising the polypeptide of claim 17 and a pharmaceutical excipient.

19. A nucleic acid encoding the polypeptide of claim 17 .

20. A vector comprising the nucleic acid of claim 19 .

21. A polypeptide comprising the amino acid sequence ETFSDIWKLLKKGFYKKKQCRPSKGRKRGFCWAVAEYARVQKRK (SEQ ID NO :223).

22. A composition comprising the polypeptide of claim 21 and a pharmaceutical excipient.

23. A nucleic acid encoding the polypeptide of claim 21 .

24. A vector comprising the nucleic acid of claim 23 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2021
From: TRANSPORIN, INC
To: ENMODULIN, INC
Reel/Frame 058769/0528 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2014
From: ONTHERIX, INC.
To: TRANSPORIN, INC.
Reel/Frame 034169/0975 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2007
From: MASCARENHAS, DESMOND
To: ONTHERIX, INC.
Reel/Frame 019585/0947 →